Magenta Therapeutics, Inc.MGTANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank6
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P6
Near historical low
vs 3Y Ago
-3.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-53.77%
Q3 2025-27.89%
Q2 202513.53%
Q1 2025-42.80%
Q4 2024-125.17%
Q3 20240.00%
Q2 20240.00%
Q3 20230.00%
Q2 202381.62%
Q1 2023-113.32%
Q4 2022-20.86%
Q3 202218.07%
Q2 202214.63%
Q1 2022-25.82%
Q4 2021-11.54%
Q3 2021-8.21%
Q2 202122.50%
Q1 2021-22.14%
Q4 20204.82%
Q3 202024.87%
Q2 2020-15.30%
Q1 2020-6.59%
Q4 2019-35.80%
Q3 201923.46%
Q2 2019-0.65%
Q1 2019-18.31%
Q4 2018-19.67%
Q3 2018-15.81%
Q2 20185.15%
Q1 2018-16.67%
Q4 2017-51.24%
Q3 2017-19.42%
Q2 2017-13.10%
Q1 20170.00%